Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus

QR Code

Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus

Michael Feher,1&ndash;3 Mark Greener,4 Neil Munro1&ndash;3,51Beta Cell Diabetes Centre, Chelsea and Westminster Hospital, London, 2Diabetes Therapies Evaluation Network, London, 3CSRI, Warwick University, Warwick, 4ROCK Medical Communications, Richmond, 5Department of Health Care Man...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Feher M, Greener M, Munro N
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2013
Sujets:	Specialties of internal medicine RC581-951
Accès en ligne:	https://doaj.org/article/4c3527219a6b492195168abc1ed0c729
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Saroglitazar for the treatment of hypertriglyceridemia in patients with type 2 diabetes: current evidence
par: Sosale A, et autres
Publié: (2015)

Treating statin-intolerant patients
par: Pigna G, et autres
Publié: (2011)

Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin
par: Ohira M, et autres
Publié: (2014)

Hypertriglyceridemia-Related Pancreatitis In Patients With Type 2 Diabetes: Links And Risks
par: Shemesh E, et autres
Publié: (2019)

Effect of different doses of statins on the development of type 2 diabetes mellitus in patients with myocardial infarction
par: Gruzdeva O, et autres
Publié: (2017)

Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus
par: Pamela Kushner
Publié: (2010)

Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus
par: Omoto S, et autres
Publié: (2015)

Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus
par: Lorber D
Publié: (2014)

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated
par: Irons BK, et autres
Publié: (2014)

Sexual dysfunction in diabetic women: prevalence and differences in type 1 and type 2 diabetes mellitus
par: Mazzilli R, et autres
Publié: (2015)

Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management
par: Nitzan O, et autres
Publié: (2015)

Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus
par: Konya H, et autres
Publié: (2013)

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]
par: Irons BK, et autres
Publié: (2017)

Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus
par: Shannon A Miller, et autres
Publié: (2009)

Clinical potential of lixisenatide once daily treatment for type 2 diabetes mellitus
par: Petersen AB, et autres
Publié: (2013)

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage [Corrigendum]
par: Wilke T, et autres
Publié: (2019)

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
par: Holl, et autres
Publié: (2014)

Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review
par: Colosia AD, et autres
Publié: (2013)

Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention
par: Alaa Badawi, et autres
Publié: (2010)

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
par: Stanley Schwartz, et autres
Publié: (2010)

Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
par: Nanne Kleefstra, et autres
Publié: (2009)

Treating the elderly diabetic patient: special considerations
par: Kezerle L, et autres
Publié: (2014)

Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements
par: Yang F, et autres
Publié: (2015)

Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
par: Jason Seewoodhary, et autres
Publié: (2010)

Holistic approach to prevention and management of type 2 diabetes mellitus in a family setting
par: Ofori SN, et autres
Publié: (2014)

Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins
par: Di Pierro F, et autres
Publié: (2015)

Glucose estimation in the salivary secretion of diabetes mellitus patients
par: Abikshyeet P, et autres
Publié: (2012)

Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase&ndash;lowering effects of garlic in patients with type 2 diabetes mellitus with obesity
par: Kumar R, et autres
Publié: (2013)

Using the health action process approach to predict and improve health outcomes in individuals with type 2 diabetes mellitus
par: MacPhail M, et autres
Publié: (2014)

Potential glycemic overtreatment in patients ≥75 years with type 2 diabetes mellitus and renal disease: experience from the observational OREDIA study
par: Penfornis A, et autres
Publié: (2015)

Long-term (52&ndash;78 weeks) treatment with colesevelam HCl added to metformin therapy in type 2 diabetes mellitus patients
par: Bays HE
Publié: (2012)

Management of gestational diabetes mellitus
par: Annunziata Lapolla, et autres
Publié: (2009)

Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability
par: Nishio S, et autres
Publié: (2015)

Risk factors associated with metabolic syndrome in type 2 diabetes mellitus patients according to World Health Organization, Third Report National Cholesterol Education Program, and International Diabetes Federation definitions
par: Angel Rodr&iacute;guez, et autres
Publié: (2010)

Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia
par: Anderson M, et autres
Publié: (2014)

Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study
par: Usharani P, et autres
Publié: (2013)

Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland
par: Huber CA, et autres
Publié: (2014)

Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
par: Ogedengbe OS, et autres
Publié: (2015)

Mechanism linking diabetes mellitus and obesity
par: Al-Goblan AS, et autres
Publié: (2014)

Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus
par: Xie J, et autres
Publié: (2019)